ATE226091T1 - Mikrokapseln mit gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstums - Google Patents
Mikrokapseln mit gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstumsInfo
- Publication number
- ATE226091T1 ATE226091T1 AT91910707T AT91910707T ATE226091T1 AT E226091 T1 ATE226091 T1 AT E226091T1 AT 91910707 T AT91910707 T AT 91910707T AT 91910707 T AT91910707 T AT 91910707T AT E226091 T1 ATE226091 T1 AT E226091T1
- Authority
- AT
- Austria
- Prior art keywords
- nerve fiber
- controlled release
- fiber growth
- release microcapsules
- stimulating nerve
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52538390A | 1990-05-16 | 1990-05-16 | |
PCT/US1991/003356 WO1991017772A1 (en) | 1990-05-16 | 1991-05-14 | Controlled release dopamine and its use to stimulate nerve fiber growth |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE226091T1 true ATE226091T1 (de) | 2002-11-15 |
Family
ID=24093026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91910707T ATE226091T1 (de) | 1990-05-16 | 1991-05-14 | Mikrokapseln mit gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstums |
Country Status (8)
Country | Link |
---|---|
US (1) | US5360610A (de) |
EP (1) | EP0528978B1 (de) |
JP (2) | JP3359919B2 (de) |
AT (1) | ATE226091T1 (de) |
DE (1) | DE69133136T2 (de) |
DK (1) | DK0528978T3 (de) |
ES (1) | ES2185615T3 (de) |
WO (1) | WO1991017772A1 (de) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693343A (en) | 1984-03-16 | 1997-12-02 | The United States Of America As Represented By The Secretary Of The Army | Microparticle carriers of maximal uptake capacity by both M cells and non-M cells |
US6217911B1 (en) | 1995-05-22 | 2001-04-17 | The United States Of America As Represented By The Secretary Of The Army | sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres |
US6309669B1 (en) | 1984-03-16 | 2001-10-30 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
USRE40786E1 (en) | 1984-03-16 | 2009-06-23 | The United States Of America As Represented By The Secretary Of The Army | Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres |
US6410056B1 (en) | 1984-03-16 | 2002-06-25 | The United States Of America As Represented By The Secretary Of The Army | Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix |
US5871472A (en) * | 1987-11-17 | 1999-02-16 | Brown University Research Foundation | Planting devices for the focal release of neuroinhibitory compounds |
US6517859B1 (en) * | 1990-05-16 | 2003-02-11 | Southern Research Institute | Microcapsules for administration of neuroactive agents |
US5618531A (en) * | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
WO1992019263A1 (en) | 1991-04-24 | 1992-11-12 | The United States Of America, As Represented By The Secretary Of The Army | Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
CA2144407C (en) * | 1992-09-10 | 2000-05-30 | Charles B. Berde | Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
US5700485A (en) * | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
US5383873A (en) * | 1992-12-09 | 1995-01-24 | Regents Of The University Of Minnesota | Smooth muscle chemical pacemaker |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6939546B2 (en) | 1993-05-21 | 2005-09-06 | The United States Of America As Represented By The Secretary Of The Army | Model for testing immunogenicity of peptides |
SK282231B6 (sk) | 1993-11-19 | 2001-12-03 | Janssen Pharmaceutica N. V. | Farmaceutický prostriedok na liečenie psychotických porúch |
US6074840A (en) | 1994-02-18 | 2000-06-13 | The Regents Of The University Of Michigan | Recombinant production of latent TGF-beta binding protein-3 (LTBP-3) |
US5763416A (en) | 1994-02-18 | 1998-06-09 | The Regent Of The University Of Michigan | Gene transfer into bone cells and tissues |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
US5962427A (en) | 1994-02-18 | 1999-10-05 | The Regent Of The University Of Michigan | In vivo gene transfer methods for wound healing |
US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
US5604198A (en) * | 1994-05-12 | 1997-02-18 | Poduslo; Joseph F. | Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents |
US6855331B2 (en) | 1994-05-16 | 2005-02-15 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
US6447796B1 (en) | 1994-05-16 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
US6902743B1 (en) | 1995-05-22 | 2005-06-07 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix |
US7033608B1 (en) | 1995-05-22 | 2006-04-25 | The United States Of America As Represented By The Secretary Of The Army | “Burst-free” sustained release poly-(lactide/glycolide) microspheres |
WO1998008464A1 (en) | 1996-08-29 | 1998-03-05 | Advanced Research & Technology Institute | Novel pharmacotherapeutic process and composition for central nervous system disorders |
AU731768B2 (en) | 1996-09-16 | 2001-04-05 | Purdue Research Foundation | Composition and method for repairing neurological tissue |
CA2296056A1 (en) * | 1997-07-10 | 1999-01-21 | Keith Baker | Methods for universally distributing therapeutic agents to the brain |
US7923250B2 (en) | 1997-07-30 | 2011-04-12 | Warsaw Orthopedic, Inc. | Methods of expressing LIM mineralization protein in non-osseous cells |
EP1007673B1 (de) | 1997-07-30 | 2008-12-17 | Emory University | Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme |
WO1999052708A1 (en) | 1998-04-13 | 1999-10-21 | Luminex Corporation | Liquid labeling with fluorescent microparticles |
US6455526B1 (en) | 1998-12-16 | 2002-09-24 | Aventis Pharmaceuticals, Inc. | Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same |
ES2245128T3 (es) * | 1998-12-16 | 2005-12-16 | Aventis Pharmaceuticals Inc. | Antagonista del receptor de serotonina encapsulado en polimero biodegradable y metodo para su preparacion. |
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
CA2406846C (en) * | 2000-04-21 | 2008-11-18 | Advanced Research And Technology Institute, Inc. | Pharmacotherapeutic process and composition for central nervous system disorders |
DE60138641D1 (de) | 2000-10-27 | 2009-06-18 | Baxter Healthcare Sa | Herstellung von mikrokügelchen |
ES2307779T3 (es) * | 2001-08-16 | 2008-12-01 | Baxter International Inc. | Formulaciones de microparticulas a base de propelentes. |
US6488952B1 (en) * | 2001-08-28 | 2002-12-03 | John P. Kennedy | Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system |
US20060076295A1 (en) | 2004-03-15 | 2006-04-13 | The Trustees Of Columbia University In The City Of New York | Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
EP1622691B1 (de) | 2003-03-14 | 2011-05-25 | The Trustees of Columbia University in the City of New York | Systeme und verfahren für auf blut basierende therapien mit einer membranlosen mikrofluid-austauschvorrichtung |
US20070092452A1 (en) * | 2003-07-18 | 2007-04-26 | Julia Rashba-Step | Methods for fabrication, uses, compositions of inhalable spherical particles |
SG135204A1 (en) * | 2003-07-18 | 2007-09-28 | Baxter Int | Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation |
US20050142205A1 (en) * | 2003-07-18 | 2005-06-30 | Julia Rashba-Step | Methods for encapsulating small spherical particles prepared by controlled phase separation |
EP1646354A4 (de) * | 2003-07-22 | 2010-03-17 | Baxter Int | Kleine kugelförmige teilchen von niedermolekularen organischen molekülen und herstellungs- und anwendungsverfahren dafür |
US7309232B2 (en) * | 2003-10-10 | 2007-12-18 | Dentigenix Inc. | Methods for treating dental conditions using tissue scaffolds |
CN103393601A (zh) | 2004-05-12 | 2013-11-20 | 巴克斯特国际公司 | 含有蛋白并在高浓度蛋白下显示可注射性的微球体 |
MXPA06012990A (es) | 2004-05-12 | 2007-02-12 | Baxter Int | Microesferas de acidos nucleicos, produccion y suministro de las mismas. |
US8728525B2 (en) | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
CN103432079A (zh) | 2004-05-12 | 2013-12-11 | 巴克斯特国际公司 | 含有寡核苷酸的微球体及其在制备用于治疗1型糖尿病的药物中的应用 |
WO2006047299A2 (en) * | 2004-10-22 | 2006-05-04 | University Of Florida Research Foundation, Inc. | Organotypic slice cultures and uses thereof |
US20060228420A1 (en) * | 2005-03-15 | 2006-10-12 | Queen Mary & Westfield College | Pharmaceutical compositions comprising microparticles for delivery into neurons |
CN101534917A (zh) | 2006-05-22 | 2009-09-16 | 纽约市哥伦比亚大学理事会 | 采用萃取流体排出流过滤的微流无膜交换系统和方法 |
WO2008006064A2 (en) * | 2006-07-07 | 2008-01-10 | Georgia Tech Research Corporation | Biomimetic polymers and uses thereof |
US7964574B2 (en) | 2006-08-04 | 2011-06-21 | Baxter International Inc. | Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
EP2077821B1 (de) | 2006-10-12 | 2019-08-14 | The University Of Queensland | Zusammensetzungen und verfahren zur modulierung von immunreaktionen |
CN100462105C (zh) * | 2006-10-19 | 2009-02-18 | 中国人民解放军第四军医大学 | 一种重组合神经替代物的制备方法 |
EP2146691A2 (de) | 2007-04-17 | 2010-01-27 | Baxter International Inc. | Nukleinsäure-mikroteilchen zur abgabe in den lungen |
CN102065926A (zh) | 2008-02-04 | 2011-05-18 | 纽约市哥伦比亚大学理事会 | 流体分离装置、系统和方法 |
MX2010011508A (es) | 2008-04-18 | 2011-05-03 | Baxter Int | Composicion basada en microesferas para prevenir y/o revertir la nueva presentacion de diabetes autoinmune. |
EP2306991B1 (de) * | 2008-06-27 | 2019-12-25 | Tepha, Inc. | Verbesserte injektionsabgabe von mikroteilchen und zusammensetzungen dafür |
EP2907531A1 (de) | 2008-07-30 | 2015-08-19 | Mesynthes Limited | Verfahren zum Trennen oder Dezellularisieren Gewebsschichten |
US8367427B2 (en) | 2008-08-20 | 2013-02-05 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8323615B2 (en) | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
US8323685B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing compositions containing microparticles |
EP2308478A1 (de) * | 2009-10-06 | 2011-04-13 | Abbott GmbH & Co. KG | Abgabesystem zur verzögerten Freisetzung von Calciumkanalblocker Arzneistoffen |
EP2635596B8 (de) | 2010-11-01 | 2020-03-11 | University of Technology Sydney | Immunmodulierende mittel und verwendungen dafür |
EP4198059A1 (de) | 2014-05-27 | 2023-06-21 | The University of Queensland | Modulation von zellulärem stress |
KR102418503B1 (ko) * | 2020-11-27 | 2022-07-07 | 주식회사 헤리노브 | 탄소섬유를 사용한 파이프 제조방법 및 이를 통해 제조된 파이프 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
JPS6048923A (ja) * | 1983-08-25 | 1985-03-16 | Mitsui Toatsu Chem Inc | 微小粒子の製造方法 |
JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
US4962091A (en) * | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
US4832686A (en) * | 1986-06-24 | 1989-05-23 | Anderson Mark E | Method for administering interleukin-2 |
JPS63122620A (ja) * | 1986-11-12 | 1988-05-26 | Sanraku Inc | ポリ乳酸マイクロスフエア及びその製造方法 |
US4883666A (en) * | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
AU632827B2 (en) * | 1989-06-21 | 1993-01-14 | Brown University Research Foundation | Neurological therapy system |
CH679207A5 (de) * | 1989-07-28 | 1992-01-15 | Debiopharm Sa | |
JP3187410B2 (ja) * | 1989-08-10 | 2001-07-11 | 住友製薬株式会社 | 脳内投与用徐放性製剤 |
-
1991
- 1991-05-14 JP JP51042891A patent/JP3359919B2/ja not_active Expired - Fee Related
- 1991-05-14 EP EP91910707A patent/EP0528978B1/de not_active Expired - Lifetime
- 1991-05-14 DE DE69133136T patent/DE69133136T2/de not_active Expired - Fee Related
- 1991-05-14 ES ES91910707T patent/ES2185615T3/es not_active Expired - Lifetime
- 1991-05-14 DK DK91910707T patent/DK0528978T3/da active
- 1991-05-14 WO PCT/US1991/003356 patent/WO1991017772A1/en active IP Right Grant
- 1991-05-14 AT AT91910707T patent/ATE226091T1/de not_active IP Right Cessation
-
1993
- 1993-03-15 US US08/033,309 patent/US5360610A/en not_active Expired - Lifetime
-
2002
- 2002-05-15 JP JP2002140490A patent/JP4044366B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69133136T2 (de) | 2003-06-18 |
DE69133136D1 (de) | 2002-11-21 |
JP2003012506A (ja) | 2003-01-15 |
JP4044366B2 (ja) | 2008-02-06 |
EP0528978B1 (de) | 2002-10-16 |
US5360610A (en) | 1994-11-01 |
EP0528978A1 (de) | 1993-03-03 |
ES2185615T3 (es) | 2003-05-01 |
WO1991017772A1 (en) | 1991-11-28 |
JPH05507486A (ja) | 1993-10-28 |
JP3359919B2 (ja) | 2002-12-24 |
EP0528978A4 (en) | 1993-06-23 |
DK0528978T3 (da) | 2003-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE226091T1 (de) | Mikrokapseln mit gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstums | |
DK0767634T3 (da) | Mikrokapsler til administration af neuroaktive midler | |
DE69203596D1 (de) | Biologisch abbaubare und biologisch absorbierbare führungskanäle zur verwendung in der behandlung und regenerierung von nerven. | |
DE69128621D1 (de) | Biokeramisches system zur abgabe von bioaktiven stoffen | |
DE69529054T2 (de) | System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung | |
ES2184895T3 (es) | Sistema no polimerico de administracion con liberacion retardada. | |
ATE129892T1 (de) | Depotimplantat mit gesteuerter wirkstoffabgabe zur behandlung von krankheiten des nervensystems. | |
BG100517A (en) | Combination of bisphosphonates and growth hormone secretagogues | |
ATE286384T1 (de) | Formulierung mit verzögerter freisetzung enthaltend kollagen und glykosaminoglykan | |
EP0322319A3 (en) | Composition comprising biodegradable ocular implants | |
DE69230112D1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
ES2133413T3 (es) | Gel de lecitina inyectable. | |
DE69530919D1 (de) | Beigeordnetes polymersystem zur verwendung mit einer medizinischen vorrichtung | |
DE69224456D1 (de) | Biologisch abbaubare Polymerzusammensetzung | |
AU6989094A (en) | Compositions and methods for treating cancer and hyperproliferative disorders | |
ATE94069T1 (de) | Verwendung von physiologisch wirksamen substanzen zur herstellung von medikamenten fuer gehirn- und nervenerkrankungen. | |
ATE89485T1 (de) | Neurologisches therapiesystem. | |
ATE149361T1 (de) | Nerveneinpflanzungssystem | |
DE60039579D1 (de) | Humane adulte astrozyten, sowie deren herstellung und verwendung | |
DE59010513D1 (de) | Medikamente zur tumortherapie mit kontrolliertem und reguliertem immunsystem sowie verwendung der einzelsubstanzen zur kombinierten therapie | |
Gonzalez-Lima | Activation of substantia gelatinosa by midbrain reticular stimulation demonstrated with 2-deoxyglucose in the rat spinal cord | |
UA27060C2 (uk) | Спосіб стимулюваhhя зовhішhьої секреції підшлуhкової залози | |
RU94039254A (ru) | Способ управления физиологическим состоянием организма в геронтологическом периоде онтогенеза |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0528978 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |